Skip to content
Bamboo Works
Search
Register / Sign in
MSCI China
|
MSCI China Small-Cap
|
Hang Seng Index
|
Hang Seng China Enterprise
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
    • China ESG Focus
  • Fast News
  • Expert Corner
  • Audio/Video
  • IPO
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • Eng
  • 简中
  • 繁中
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
    • China ESG Focus
  • Fast News
  • Expert Corner
  • Audio/Video
  • IPO
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

Tong Ren Tang

Tong Ren Tang does healthcare

Tong Ren Tang Healthcare makes trading debut, backed by 39% annual patient growth

The company will use a majority of the $68 million it raised from its Hong Kong listing to expand its network of traditional Chinese medicine hospitals and clinics Key Takeaways:…
July 7, 2026
Tong Ren Tang launches IPO

Tong Ren Tang kicks off IPO leveraging time-honored medicinal brand to offer healthcare

One of China’s oldest medical names has applied to list its Tong Ren Tang Healthcare Investment unit, which is building an integrated healthcare system Key Takeaways: Top-rated non-public traditional Chinese…
March 23, 2026
2667.HK
Tong Ren Tang Healthcare making its fourth listing bid

Chinese medicine firm seeks elusive elixir of IPO success

The healthcare services arm of the Tong Ren Tang group enjoys a high-profile TCM brand, but its profit margins lag far behind industry peers Key Takeaways: Tong Ren Tang Healthcare…
February 5, 2026
From ‘magic tea’ to dietary drugs, can Besunyen reclaim its glory days?

From ‘magic tea’ to dietary drugs, can Besunyen reclaim its glory days?

Once a household name known for its ‘slimming tea,’ the company is looking for a new formula in dietary drugs after years of losses and asset sales Key Takeaways: Besunyen…
August 13, 2025
0926.HK
Scientists make new birds nest based products

Yan Palace flies back to profit growth as revenue sags

The birds-nest products maker’s profit rose about 3.8% in the second half of last year, reversing a decline in the first half, even as its second-half revenue fell 2% Key…
February 17, 2025
1497.HK

Recent Articles

Tong Ren Tang does healthcare
July 7, 2026

Tong Ren Tang Healthcare makes trading debut, backed by 39% annual patient growth

March 23, 2026

Tong Ren Tang kicks off IPO leveraging time-honored medicinal brand to offer healthcare

2667.HK
February 5, 2026

Chinese medicine firm seeks elusive elixir of IPO success

August 13, 2025

From ‘magic tea’ to dietary drugs, can Besunyen reclaim its glory days?

0926.HK
February 17, 2025

Yan Palace flies back to profit growth as revenue sags

1497.HK

RELATED ARTICLES

  1. Tong Ren Tang launches IPO
    March 23, 2026
    Tong Ren Tang kicks off IPO leveraging time-honored medicinal brand to offer healthcare
    2667.HK
  2. February 5, 2026
    Chinese medicine firm seeks elusive elixir of IPO success
  3. June 30, 2026
    JBM Healthcare gets bitter pill from investors on anemic performance
    2161.HK
  4. April 20, 2026
    Good Doctor Cloud Healthcare’s ailing margins belie uninspired new listing
  5. April 30, 2026
    Looking for overseas growth, Aier Eye seeks Hong Kong listing
    300015.SHE
  6. June 9, 2026
    BRIEF: Chairman Tang Ning boosts indirect stake in Yiren Digital
    YRD.US
  7. April 24, 2026
    Yidu Tech swings to profit as AI healthcare edges toward viability
    2158.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

China stock insights and analysis for global investors: Bamboo Works unlocks investment opportunities in Chinese companies listed in the U.S. & Hong Kong.

  • About Us
  • Fast News
  • Audio/Video
  • Expert Corner
  • China ESG
Facebook Twitter Linkedin Weixin Weibo Youtube

Categories

  • New Energy
  • IPO
  • AI/Infrastructure/Resources
  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • Property

Newsletter

Discover hidden China stock gems in our weekly newsletter
Copyright © 2021 - 2026 Bamboo Works. All rights reserved.